Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Magnum Ice Cream results fail to impress as operating profit slides

(Sharecast News) - Shares in Magnum Ice Cream tumbled on Thursday as its first full-year results since the recent demerger from Unilever failed to impress. The maker of Cornetto and Ben & Jerry's said full-year pre-tax profit slumped 48.7% to €307m, while operating profit declined to €599m from €764m.

Revenue was flat at €7.9bn, with organic sales growth of 4.2%. Volume growth was 1.5% while price growth was 2.6%.

Free cash flow for the year came in at €38m, down from €803m in 2024. The company said this was mainly due to the significant cash outflows related to the demerger, implementation of the interim operating model, interest costs on new loans, and TSAs with Unilever.

The adjusted EBITDA margin fell to 15.9% from 16.9% a year earlier, impacted by forex translation effects and previously allocated depreciation costs.

For 2026, organic sales growth is expected to be between 3% and 5%, with and expected adjusted EBITDA margin improvement of 40 to 60 basis points.

Chief executive Peter Ter Kulve said: "We delivered a solid operational performance in 2025, with broad-based organic sales growth of 4.2%, outperforming the growing global ice cream market and consolidating our leading position whilst we delivered a complex company separation.

"I am particularly pleased with our 1.5% volume growth, reflecting the continued momentum behind our well-loved brands. Our four leading brands, Magnum, Ben & Jerry's, Cornetto and the Heartbrand, were the driving force behind our performance, with 150 new launches, including Magnum Utopia and Cornetto Max."

At 1035 GMT, the shares were 13.6% lower at 1,232.50p.

Dan Coatsworth, head of markets at AJ Bell, said: "The Magnum Ice Cream Company has seen its share price melt faster than a Cornetto left in the sun after its maiden results as an independent entity.

"The spin-off from Unilever meant the results were always likely to be messy with one-off costs associated with the split.

"However, investors were still unimpressed by the big drop in annual profit and cash flow, raising questions about how the process was communicated and managed. The share price sell-off suggests lots of Unilever holders were looking for any excuse to offload the Magnum shares they were handed as part of the demerger.

"From Unilever's perspective it just reinforces the decision to exit the ice cream business to focus on its core brands. Ice cream is seasonal and has higher storage and distribution costs.

"A further concern for the market is the potential impact of weight-loss drugs on people's appetite for high calorie, indulgent ice cream products."

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.